ArticleRoyal Society open science2026
Design principles for natural SGLT2 modulators from multi-scale computation.
Article in Royal Society open science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Design principles for natural SGLT2 modulators from multi-scale computation.Royal Society open science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human sodium-glucose cotransporter 2 (hSGLT2) is a membrane-embedded renal transporter and an established therapeutic target for type 2 diabetes. Hyperoside, myricetin, cyanidin-3-O-glucoside and isoliquiritigenin were investigated as a chemically diverse panel of natural scaffolds using a multi-scale computational workflow combining redocking-validated molecular docking, reconstruction of an unresolved transporter segment, molecular dynamics (MD) in an explicit POPC bilayer, molecular mechanics/Poisson-Boltzmann surface area (MM/PBSA) calculations, principal component and free-energy landscape analyses and density functional theory (DFT). The membrane simulations preserved the global hSGLT2 fold while revealing distinct ligand-dependent binding behaviours. Myricetin and cyanidin-3-O-glucoside exhibited limited positional deviations; hyperoside achieved persistent accommodation following an initial adjustment, whereas isoliquiritigenin underwent a marked late rearrangement. Ensemble-based energetic analysis prioritized cyanidin-3-O-glucoside, while hyperoside and myricetin formed an energetically comparable intermediate group and isoliquiritigenin displayed the least favourable profile. Electronic-structure analysis further characterized cyanidin-3-O-glucoside as the most responsive ligand within the DFT subset. Collectively, these findings indicate that glycone-assisted polar anchoring, aromatic complementarity and restricted conformational flexibility promote persistent hSGLT2 recognition. Direct hSGLT2 inhibition and hSGLT1 counter-screening assays remain necessary to establish potency and selectivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.